
Continuing education and networking can help pharmacists stay current with the profession

Continuing education and networking can help pharmacists stay current with the profession

Specific drugs, foods, and supplements can lead to this condition.

Pharmacy Times provides a comprehensive recap of the latest advancements in hematology and breast cancer, shared at the 2023 American Society of Hematology and the San Antonio Breast Cancer Symposium conferences

Partnering with a franchisor can provide a support system and resources for pharmacies looking to diversify revenue

Radioligands may be able to deliver radiation to advanced tumor cells anywhere in the body.

No established standard of care currently exists after spread to the lymph nodes.

Please take 10 minutes to complete the 2024 Burnout and Mental Health Survey.

Compared to TACE alone, durvalumab plus TACE and bevacizumab reduced the risk of disease progression or death by 23%; however, further research is needed to assess OS.

Older patients’ underrepresentation in clinical trials leaves a gap in data regarding appropriate treatment.

In hospital pharmacies, roughly 2% of pharmacy spend can be overcharge.

These patients may have a similar genetic susceptibility for type 2 diabetes.

Pharmacists can also ensure proper education and selection of therapy before and after discharge.

By offering personalized guidance, promoting awareness, and fostering open communication, pharmacists can empower their patients to navigate the new year with a focus on both wellness and safety.

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, discusses the multifaceted role of oncology pharmacists in diverse care settings, emphasizing their collaboration in treatment decisions and adaption in the evolving landscape of cancer care.


The combination resulted in numerically longer OS compared with an NSAI alone.

Pharmacy owner submitted fake claims stating that patients used coupons

Jennifer Marsh, PharmD, BCCCP, discusses the current standard of care for hepatic encephalopathy, highlighting challenges in treatment, prescription drug coverage, transition of care, and outpatient treatment access.

The approval marks dupilumab as the first and only FDA-approved medicine to treat pediatric patients with eosinophilic esophagitis.

The candidate has already demonstrated anti-tumor activity in chemotherapy-naïve patients.


Creating additional space for nursing mothers can be challenging in small pharmacies

Since 2000, as the number of CDIs has surged, morbidity and mortality also have increased.

Treating older patients requires a greater focus on treating their AD without exacerbating their comorbidities.

Gabriella Farkas, MD PhD, addresses the multifaceted role of pharmacists in the mental health and wellness space

A risk-stratification screening approach that considers screening at an earlier age based on risk factors might increase the likelihood of catching the cancer before it turns symptomatic.

The MRD-guided treatment approach has a significant advantage over chemotherapy.

Migraine headaches are considered a leading cause of disability around the world.

Tune in to this special episode for an exclusive insight into the future of health technology and wearable innovation, including a glimpse into the world of CES 2024.

According to the FDA review, patients with CKD receiving denosumab for osteoporosis who are on dialysis or have CKD-MBD are at the highest risk of severe hypocalcemia.